PERFORMANCE OF PROMIS-29 (PATIENT REPORTED OUTCOMES MEASUREMENT INFORMATION SYSTEM-29) IN PATIENTS OF RHEUMATIOD ARTHRITIS

Código QR

PERFORMANCE OF PROMIS-29 (PATIENT REPORTED OUTCOMES MEASUREMENT INFORMATION SYSTEM-29) IN PATIENTS OF RHEUMATIOD ARTHRITIS

Objective: To determine the performance of patient reported outcome measurement information system in patients with rheumatoid arthritis in our setup. Study Design: Cross sectional study. Place and Duration of Study: Division of Rheumatology, Fatima memorial hospital, Lahore Pakistan, from May...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Naveed Aslam Lashari, Saira E.A Khan, Shabnam Batool, Asadullah Khan, Zia u din
Formato:	article
Lenguaje:	EN
Publicado:	Army Medical College Rawalpindi 2021
Materias:	disease activity score-28 disease modifying anti rheumatic drugs low disease activity patient reported outcome measurement information system-29 rheumatoid arthritis Medicine R Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/bbd56b817c754138a7174d5736b379b4
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Prevalence and clinical characteristics of rheumatoid arthritis in Poland: a nationwide study
por: Bogdan Batko, et al.
Publicado: (2018)

Efficacy and safety of various anti-rheumatic treatments for patients with rheumatoid arthritis: a network meta-analysis
por: Kexun Ma, et al.
Publicado: (2018)

Psychometric validation of the Korean version of PROMIS 29 Profile V2.1 among patients with lower extremity problems
por: Youngha Kim, et al.
Publicado: (2021)

Artritis reumatoidea en población mapuche.: Una experiencia de 16 años en la IX región de Chile
por: Kaliski K,Sonia, et al.
Publicado: (2001)

Valor pronóstico del índice de Sharp en la respuesta clínica y de laboratorio a un pulso intravenoso de metilprednisolona en pacientes con artritis reumatoídea
por: Cuchacovich T,Miguel, et al.
Publicado: (2000)

Características de la hospitalización reumatológica en un hospital de nivel terciario
por: Pacheco R,Daniel, et al.
Publicado: (2001)

A Comparison of Demographics, Disease Activity, Disability, and Treatment Among Rheumatoid Arthritis Patients with and without Osteoporosis
por: Abdulkhaliq A, et al.
Publicado: (2021)

Clinical and serological characteristics of Ecuadorian patients with rheumatoid arthritis
por: Ríos C, et al.
Publicado: (2017)

Adalimumab impact on fatigue measured by FACIT-F: a study of rheumatoid arthritis patients in Saudi Arabia
por: Janoudi N, et al.
Publicado: (2017)

Is pentraxin 3 level an effective biomarker in disease activity in patients with rheumatoid arthritis?
por: Ozlem Balbaloglu, et al.
Publicado: (2019)

Color fraction as a useful method of imaging synovium vascularization in patients with high activity of rheumatoid arthritis
por: Michał Jakubaszek, et al.
Publicado: (2020)

European journal of rheumatology

Translation and adaptation of the EORTC QLQ-LC 29 for use in Chinese patients with lung cancer
por: Wei Dai, et al.
Publicado: (2021)

Impact of Non-Persistence on Healthcare Resource Utilization and Costs in Patients With Immune-Mediated Rheumatic Diseases Initiating Subcutaneous TNF-Alpha Inhibitors: A Before-and-After Study
por: Nuria Carballo, et al.
Publicado: (2021)

Fer exacerbates renal fibrosis and can be targeted by miR-29c-3p
por: Sun Chen-Min, et al.
Publicado: (2021)

Evaluation of C-Reactive Protein and Associated Factors Among Patients Suffering from Rheumatoid Arthritis at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia
por: Dessie G, et al.
Publicado: (2021)

Archives of rheumatology

Use of the rheumatic drug tocilizumab for treatment of SARS-CoV-2 patients
por: Bogna Grygiel-Górniak, et al.
Publicado: (2021)

Editorial: Therapeutic Implications for Pregnant Women With Systemic Autoimmune Diseases and Their Children
por: Cecilia Beatrice Chighizola, et al.
Publicado: (2021)

Should we be Afraid of Immune Check Point Inhibitors in Cancer Patients with Pre-Existing Rheumatic Diseases? Immunotherapy in Pre-Existing Rheumatic Diseases
por: Kalliopi Klavdianou, et al.
Publicado: (2021)

EFFICACY AND SAFETY OF SIMVASTATIN IN RHEUMATOID ARTHRITIS: AN OPEN-LABEL, CONTROLLED STUDY
por: I. V. Shirinsky, et al.
Publicado: (2014)

Adverse Impact of Rheumatoid Arthritis on Pregnancy Outcomes: A Saudi Arabia Prospective Multicenter Study
por: Al Rayes H, et al.
Publicado: (2021)

Conventional disease-modifying agents in rheumatoid arthritis – a review of their current use and role in treatment algorithms
por: Ivan Padjen, et al.
Publicado: (2020)

Granulocyte and monocyte/macrophage apheresis for the treatment of immune-mediated inflammatory arthropathies: case reports
por: Ana Victoria Carro Martínez, et al.
Publicado: (2021)

SENSITIZATION TO STREPTOCOCCUS PYOGENES AT CHILDREN OF EARLY AND PRESCHOOL AGE WITH RECURRENT RESPIRATORY INFECTIONS — PREDICTORS OF RHEUMATIC PATHOLOGY
por: E. V. Shabaldina, et al.
Publicado: (2015)

Gut Microbiota–Medication Interaction in Rheumatic Diseases
por: Lingshu Zhang, et al.
Publicado: (2021)

Rheumatic fever: New ideas in diagnosis and management
por: John Lawrenson
Publicado: (2017)

EFFECTS OF STATINS AND OTHER BIOLOGICAL PREPARATIONS UPON ACTIVATION OF MITOGEN-ACTIVATED PROTEIN KINASES IN PATIENTS WITH RHEUMATOID ARTHRITIS
por: I. V. Shirinsky, et al.
Publicado: (2014)

Physical activity and sedentary behavior in women with rheumatoid arthritis: a comparison of patients with low and high disease activity and healthy controls
por: Summers G, et al.
Publicado: (2019)

TRANSNSLOCACIÓN ROBERTSONIANA (1;29) EN BOVINOS CRIOLLOS COLOMBIANOS
por: Sánchez CA, et al.
Publicado: (2006)

Migraine in patients with rheumatoid arthritis and its relation to disease activity
por: Hassan Abd-Elaty El-Sonbaty, et al.
Publicado: (2021)

Frecuencia de anticuerpos para diagnóstico de enfermedad celíaca en pacientes con enfermedades del tejido conectivo y artropatías inflamatorias
por: Rodríguez,Graciela Rita, et al.
Publicado: (2014)

Improved assembly procedure of viral RNA genomes amplified with Phi29 polymerase from new generation sequencing data
por: Berthet,Nicolas, et al.
Publicado: (2016)

Clinical utility of anti-carbamylated antibody in rheumatoid arthritis female patients: Emerging predictive value compared to anti-cyclic citrullinated peptide and rheumatoid factor
por: Ahmed E. Hafez, et al.
Publicado: (2022)

Comparison of Indexes to Measure Comorbidity Burden and Predict All-Cause Mortality in Rheumatoid Arthritis
por: Yun-Ju Huang, et al.
Publicado: (2021)

Achieving comprehensive remission or low disease activity in rheumatoid patients and its impact on workability – Saudi Rheumatoid Arthritis Registry
por: Almoallim H, et al.
Publicado: (2019)

Proteomic Approaches to Defining Remission and the Risk of Relapse in Rheumatoid Arthritis
por: Liam J. O’Neil, et al.
Publicado: (2021)

Rheumatological aspects of pathogenesis and treatment of COVID-19 infection
por: Desislava Kalinova, et al.
Publicado: (2020)

Evaluation of autoantibodies against vimentin and α-enolase in rheumatoid arthritis patients
por: Mina Ebrahimi-Rad, et al.
Publicado: (2020)

SPONTANEOUS IMMUNOGLOBULIN-SYNTHESIZING ACTIVITY OF B LYMPHOCYTES IN INFLAMMATORY RHEUMATIC DISEASES
por: A.T. T. Mamasaidov, et al.
Publicado: (2014)